<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2023.135081</article-id><article-id pub-id-type="publisher-id">OJOG-125430</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Factors Associated with Mother-to-Child Transmission of HIV at the Maternity Unit of the Castors Urban Health Center in Bangui
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Thibaut</surname><given-names>Boris Clavaire Songo-Kette Gbekere</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gilles</surname><given-names>Davy Kossa-Ko-Ouakoua</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gertrude</surname><given-names>Rose De Lima Kogboma Wongo Guerengbo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rodrigue</surname><given-names>Herman Doyama-Woza</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Siméon</surname><given-names>Matoulou-M’bala Wa-Ngogbe</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alida</surname><given-names>Koirokpi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sabrina</surname><given-names>Ouapou</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kelly</surname><given-names>Mbano-Dede Matike-Ayamboka</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Josué</surname><given-names>Eezchiel Sandjima</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Norbert</surname><given-names>Richard Ngbale</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>The Maternity Unit of the Centre de Santé Urbain des Castors, Bangui, Central African Republic</addr-line></aff><aff id="aff2"><addr-line>Department of Gynecology and Obstetrics, Centre Hospitalier Universitaire Communautaire, Bangui, Central African Republic</addr-line></aff><aff id="aff3"><addr-line>Department of Public Health, Faculty of Health Sciences, University of Bangui, Bangui, Central African Republic</addr-line></aff><aff id="aff4"><addr-line>Department of Gynecology and Obstetrics, Centre Hospitalier Universitaire Maman Elisabeth Domitien, Bimbo, Central African Republic</addr-line></aff><pub-date pub-type="epub"><day>24</day><month>05</month><year>2023</year></pub-date><volume>13</volume><issue>05</issue><fpage>950</fpage><lpage>959</lpage><history><date date-type="received"><day>16,</day>	<month>September</month>	<year>2022</year></date><date date-type="rev-recd"><day>28,</day>	<month>May</month>	<year>2023</year>	</date><date date-type="accepted"><day>31,</day>	<month>May</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction
  : 
  In spite of significant progress towards eliminating mother-to-child transmission (MCT) of HIV by 2025, trends in vertical mother-to-child transmission are still worrying in sub-Saharan African countries. This study aims to take stock of the factors associated with HIV MCT at the level of peripheral health training.<b> Patients and Methods: </b>This was a descriptive and analytical retrospective study, over a five-year period from January 1<sup>st</sup>, 2017 to December 31<sup>st</sup>, 2021. The study population was represented by HIV-positive women and their cared infants in the Parent-Child Transmission Prevention Unit (PCTP) of the Castors Urban Health Center (CUHC). <b>Results: </b>288 medical records were selected out of a total of 347 HIV-positive mothers followed. HIV seroprevalence in the population of women who received PreNatal Consultation (PNC) during the study period was 8.2%. The HIV MCT rate was 3.7%. HIV+ mothers followed were mostly young (average age of 28), not living in a couple (96.9%), poorly educated (58.7%) and not engaged in income-generating activity (58
  .
  4%).
   
  They had all received triple therapy and the period of initiation of antiretroviral (ARV) therapy was in the majority of cases during the first trimester. Factors associated with MCT were: primiparity (OR = 18.4 [5.55 - 61.05]; Khi<sup>2</sup> = 32.61; p &lt; 0.001), late discovery of infection during large or after childbirth (OR = 0.03 [0.007 - 0.10]; Khi<sup>2</sup> = 55.22; p &lt; 0.001), WHO Clinical Stage 2 and 3 (OR = 0.007 [0.001 - 0.03]; Khi<sup>2</sup> = 108.73; p &lt; 0.001), CD4 count 200/mm<sup>3</sup> (OR = 14.12 [4.03 - 57.20]; Khi<sup>2</sup> = 21.68; p &lt; 0.001), viral load &gt;
   
  1000 copies/mm<sup>3</sup> (OR = 8.85 [2.33 - 43.20]; Khi<sup>2</sup> = 10.46; p = 0.001), prolonged labor (OR = 12.33 [3.45 - 57.25]; Khi<sup>2</sup> = 18.47; p &lt; 0.001), premature rupture of membranes (OR = 24.03 [6.97 - 96.01]; Khi<sup>2</sup> = 40.60; p &lt; 0.001), low birth weight (OR = 4.67 [1.42 - 17.88]; Khi<sup>2</sup> = 5.96; p = 0.014), and artificial or mixed breastfeeding (OR = 0.01 [0.002 - 0.043]; Khi<sup>2</sup> = 97.65; p &lt; 0.0001. <b>Conclusion: </b>Taking into account the risk factors for PCTP is essential if we want to achieve the goal of 
  “
  Zero New Infections in Children by the year 2025”.
 
</p></abstract><kwd-group><kwd>Factors</kwd><kwd> Transmission</kwd><kwd> Mother-Child</kwd><kwd> HIV</kwd><kwd> Bangui</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Human immunodeficiency virus (HIV) infection is a major public health and development problem in sub-Saharan African countries [<xref ref-type="bibr" rid="scirp.125430-ref1">1</xref>] . It is estimated that nearly two-thirds of people living with HIV reside in the African region [<xref ref-type="bibr" rid="scirp.125430-ref2">2</xref>] . In the Central African Republic (CAR), where there is a generalized HIV epidemic with a prevalence of around 3.7% in 2015, including 4.3% among women of childbearing age [<xref ref-type="bibr" rid="scirp.125430-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref4">4</xref>] , indicators for the prevention of mother-to-child transmission (PMTCT) are still alarming. According to UNAIDS estimates in 2020 [<xref ref-type="bibr" rid="scirp.125430-ref5">5</xref>] , the number of new infections among children under 14 years old from 940 in 2015 to 510 in 2019. Similarly, the percentage of pregnant women with access to ARVs is increased from 32% in 2010 to 94% in 2019. This remarkable increase is however still associated with an overall high rate of MTCT of 12%, well above the acceptable threshold less than 5% of the WHO [<xref ref-type="bibr" rid="scirp.125430-ref5">5</xref>] . In order to achieve the objectives for eMTCT, the CAR has an emergency plan since 2017 to accelerate access to ARVs for HIV-positive pregnant women [<xref ref-type="bibr" rid="scirp.125430-ref6">6</xref>] . This study aims to make an inventory of the implementation of the main recommendations for ETMC at the level of a peripheral health facility through a review of five years of activity of the PMTCT service.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>The study took place at the Centre de Sant&#233; Urbain des Castors (CSU-C), created in 1955. This is a cross-sectional study over a period of five years from January 01, 2017 to December 31, 2021. The study population was represented by HIV-positive women and exposed infants cared for in the PCTP Unit of the CSU-C. Were Included in our study: All HIV-positive women attending prenatal care with an updated medical record; all exposed infants who received ARV prophylaxis and early HIV screening with an updated medical record. Were excluded: All HIV-positive pregnant women followed who miscarried or died; Exposed newborns who died before having carried out early HIV screening according to national recommendations (PCR1 at 6 weeks, PCR 2 at 9 or 12 months and HIV serology at 18 months of life). The sample consists of all exposed women and infants meeting the inclusion criteria. Our study received the favorable opinion of the ethics committee. Data were entered and analyzed using Epi info software 7. The statistical tests used for the comparison were Yates’ Chi-square and Ficher’s test. The difference was significant if p &lt; 0.05. The texts and tables were entered with Microsoft Office 2013, Word and Excel software. Anonymity was required. The various information has been treated with respect for confidentiality.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Prevalence of PMTCT</title><p>During the period, 4276 pregnant women were followed in the unit of prenatal care of CSU-C in which 4236 realized a HIV serology between the prenatal care. A total of 288 were selected for the study taking into the study criteria. Thus, HIV prevalence was 6.7% among pregnant women. Thus 13 newborns tested positive. The rate of HIV transmission from mother to child was 4.5%.</p></sec><sec id="s3_2"><title>3.2. Sociodemographic Characteristics of Mothers</title><p>The average age of the patients was 28 years &#177; 6 with extremes of 15 and 41 years. The age group of 25 to 29 years old was the most represented (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Level of education and profession</p><p>More than half of the patients had not reached the secondary level and most of them did not have an income-generating activity (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of patients by age</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age range</th><th align="center" valign="middle" >Numbers</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >≤19 years old</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >4.9</td></tr><tr><td align="center" valign="middle" >20 to 24 years old</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >21.2</td></tr><tr><td align="center" valign="middle" >25 to 29 years old</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >30 to 34 years old</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >25.3</td></tr><tr><td align="center" valign="middle" >≥35 years old</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >11.1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >288</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients according to level of education and profession</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameters</th><th align="center" valign="middle" >Number (n = 288)</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle"  colspan="3"  >Educational level</td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >4.5</td></tr><tr><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >156</td><td align="center" valign="middle" >54.2</td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >31.2</td></tr><tr><td align="center" valign="middle" >University</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >10.1</td></tr><tr><td align="center" valign="middle"  colspan="3"  >Profession</td></tr><tr><td align="center" valign="middle" >Tradeswoman</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >37.5</td></tr><tr><td align="center" valign="middle" >Student</td><td align="center" valign="middle" >101</td><td align="center" valign="middle" >35.1</td></tr><tr><td align="center" valign="middle" >Household</td><td align="center" valign="middle" >67</td><td align="center" valign="middle" >23.3</td></tr><tr><td align="center" valign="middle" >Officer</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >4.1</td></tr></tbody></table></table-wrap><p>Matrimonial statut</p><p>Singles were the most represented.</p></sec><sec id="s3_3"><title>3.3. Factors Associated with Mother-to-Child Transmission of HIV</title></sec></sec><sec id="s4"><title>4. Discussion</title><p>MTCT rate</p><p>In our study, all the mothers were on triple therapy during pregnancy, in accordance with the guidelines of option B+ which has been implemented at the country level since 2013 [<xref ref-type="bibr" rid="scirp.125430-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref10">10</xref>] . Several studies have shown the benefit of this method in reducing vertical transmission of HIV [<xref ref-type="bibr" rid="scirp.125430-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref14">14</xref>] . We found a rate of MTCT of 4.5%, which is in line with WHO recommendations which set a threshold of &lt;5% for HIV+ mothers benefiting from option B+ [<xref ref-type="bibr" rid="scirp.125430-ref12">12</xref>] . Our results can be left on those of several countries in the African series that have adopted option B+. Indeed, Gabouga et coll. in Bangui [<xref ref-type="bibr" rid="scirp.125430-ref15">15</xref>] , Njom et coll. in Cameroon [<xref ref-type="bibr" rid="scirp.125430-ref16">16</xref>] and Girma et coll. in Ethiopia [<xref ref-type="bibr" rid="scirp.125430-ref17">17</xref>] found respectively in their series, MTCT rates of 4.1%, 4.8% and 4.9%. However, our findings are significantly lower than those of Diemer et coll. [<xref ref-type="bibr" rid="scirp.125430-ref18">18</xref>] and Ngbale et coll. [<xref ref-type="bibr" rid="scirp.125430-ref19">19</xref>] , both in Bangui. Indeed, these authors in 2013 and 2017 had noted a slightly higher transmission rate of 7% and 8.3%, in the PPTPE sites in Bangui as well as at the Centre hospitalier universitaire communautaire of Bangui. This difference could be explained by the fact that in 2013-2014, HIV+ mothers were still in option A. These results corroborate the undeniable benefit of implementing option B+ compared to option A, for PMTCT of HIV. Indeed, it must be said that in several studies conducted in African countries on the use of option A for PMTCT, MTCT rates varied between 8% and 23% [<xref ref-type="bibr" rid="scirp.125430-ref20">20</xref>] . Nevertheless, it is necessary to underline the insufficiencies as regards the follow-up of infants exposed. Indeed, while 95.5% of infants completed PCR1 on time, only 1.8% came back on time for PCR2. This observation could be linked to the feeling of security for the mothers when the PCR1 is negative, and therefore, she thinks that it is not necessary to repeat a PCR2. It should also be noted that the average delay in reporting results of 2 to 3 months is also a limiting factor for the follow-up of exposed infants.</p><p>Factors associated with mother-to-child transmission of HIV</p><p>MTCT and maternal characteristics</p><p>Statistically in our study, univariate analysis showed that MTCT is not significantly related to maternal sociodemographic characteristics (maternal age, level of education, occupation and marital status) (p &gt; 0.05). This observation is similar to that of Hoffmann who finds that maternal age and social status are not risk factors for vertical transmission [<xref ref-type="bibr" rid="scirp.125430-ref21">21</xref>] . On the other hand, for some authors, marital status was associated with MTCT [<xref ref-type="bibr" rid="scirp.125430-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref23">23</xref>] . For the latter, mothers who are not married were 8 times more likely to have an HIV-infected child compared to those who are married. We also noted that seropositive primiparous women have an 18 times higher risk of MTCT than multiparous women (OR = 18.4 [5.55 - 61.05]; p &lt; 0.001). Bucagu in Rwanda made the same observation [<xref ref-type="bibr" rid="scirp.125430-ref24">24</xref>] .</p><p>MTCT and maternal factors related to HIV status</p><p>Advanced immunosuppression translates clinically into an advanced clinical stage according to the WHO and the occurrence of opportunistic infections; and biologically by increasing viral load and decreasing CD4 count. The more advanced the immune suppression, the higher the transmission rate [<xref ref-type="bibr" rid="scirp.125430-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref25">25</xref>] . High maternal plasma viral load also remains the main biological predictor of both early and late MTCT [<xref ref-type="bibr" rid="scirp.125430-ref26">26</xref>] .</p><p>In our series, the main factors related to MTCT in relation to maternal HIV status are WHO clinical stage, CD4 count at treatment initiation and VL, with a statistically significant difference (p &lt; 0.05). Also, those with a CD4 count &lt; 200/mm<sup>3</sup> are 14 times more likely to transmit HIV to their child. Similarly, those who have a detectable viral load before delivery are 8 times more likely to transmit HIV to their child.</p><p>Labor flow factors associated with MTCT</p><p>By observing the factors related to the course of labor in the HIV+ mothers of our study, it appears that two main factors are incriminated for the MTCT of HIV. These are the existence of a PRM and prolonged labor, all with a statistically significant difference (p &lt; 0.05). These findings are superimposed on those of the literature. Indeed, premature rupture of membranes is associated with vertical transmission of HIV [<xref ref-type="bibr" rid="scirp.125430-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref28">28</xref>] because prolonged rupture of the membranes before delivery would favor the transmission of HIV during labor and delivery [<xref ref-type="bibr" rid="scirp.125430-ref27">27</xref>] . A study carried out in Bangkok had found the presence of HIV in genital secretions. It has thus been postulated that these virions could access the uterine cavity during pregnancy, more particularly during labour. Perinatal TME would then take place by the ascending route [<xref ref-type="bibr" rid="scirp.125430-ref26">26</xref>] . Mode of delivery did not show a statistically significant difference with respect to MTCT. This observation is also made by other African authors [<xref ref-type="bibr" rid="scirp.125430-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref30">30</xref>] . The lack of association between the mode of delivery and MTCT could be explained by the fact that, in countries with limited resources, elective caesareans are rarely performed and the indications for caesarean in general are guided mainly by the necessities of obstetrics rather than HIV infection [<xref ref-type="bibr" rid="scirp.125430-ref30">30</xref>] . Several studies have shown that an elective caesarean section is a protective factor, and would lead to a significant reduction in the risk of MTCT compared to vaginal delivery [<xref ref-type="bibr" rid="scirp.125430-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref31">31</xref>] . Therefore, as a result of this evidence, the American College of Obstetricians and Gynecologists and the Department of Health and Human Services Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission has developed guidelines recommending childbirth by elective caesarean section for HIV-infected women with a plasma viral load of more than 1000 copies/mL.</p><p>Newborn factors that are associated with MTCT</p><p>With regard to birth weight, our study reports that children with low birth weight had a 4 times higher risk of being infected (OR = 4.67 [1.42 - 17.88]; p = 0.014). Contrary to our results which are comparable to those of other authors [<xref ref-type="bibr" rid="scirp.125430-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref33">33</xref>] , Hoffmann finds no significant association between low birth weight and MTCT [<xref ref-type="bibr" rid="scirp.125430-ref21">21</xref>] . This susceptibility of low birth weight newborns could be attributed to the fact that these newborns are more exposed to neonatal pathologies. This would favor their infection with HIV.</p><p>The question of breastfeeding remains a dilemma for many HIV-positive mothers, at the risk of being rejected or stigmatized, as Oladokun shows in her study [<xref ref-type="bibr" rid="scirp.125430-ref28">28</xref>] . This ultimately leads to inappropriate infant feeding practices as evidenced by the rate of mixed feeding practiced by HIV-positive mothers in this study. Many women, after having chosen formula feeding, practice mixed feeding, which is the riskiest method in vertical transmission. We found that HIV infection was significantly associated with mixed feeding. This observation is similar to those reported in several studies [<xref ref-type="bibr" rid="scirp.125430-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref37">37</xref>] . There is evidence that mixed feeding, compared to exclusive breastfeeding and strict artificial feeding, is associated with an increased risk of HIV transmission [<xref ref-type="bibr" rid="scirp.125430-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.125430-ref37">37</xref>] . During mixed feeding, the beneficial immune factors in breast milk are likely outweighed by damage to the child’s gut wall, contaminants or allergens in the mixed feed [<xref ref-type="bibr" rid="scirp.125430-ref37">37</xref>] . On the other hand, exclusive breastfeeding promotes the maintenance of the integrity of the child’s gastrointestinal barrier (considered as the main mode of infection). It is also established that immunological factors in breast milk are likely to reduce viral activity in human milk [<xref ref-type="bibr" rid="scirp.125430-ref37">37</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>Preventing mother-to-child transmission of HIV is essential to reducing the spread of infection within families. Its main objective is to reduce the vertical transmission of HIV from mother to child. Admittedly, the rate of MTCT of HIV is satisfactory at the level of the CSU-C, but insufficiencies remain as regards the biological monitoring of the mothers as well as in respecting the deadlines for early detection according to the recommendations at the national level. If we want to achieve the objective advocated by the WHO which is “Zero New Infections”, especially among children from the year 2025, it is necessary to strengthen the PMTCT service offer at all levels of the health pyramid.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Gbekere, T.B.C.S.-K., Kossa-Ko-Ouakoua, G.D., Guerengbo, G.R.D.L.K., Doyama-Woza, W.R.H., Wa-Ngogbe, S.M.M., Koirokpi, A., Ouapou, S., Matike-Ayamboka, K.M.D., Sandjima, E. and Ngbale, N.R. (2023) Factors Associated with Mother-to-Child Transmission of HIV at the Maternity Unit of the Castors Urban Health Center in Bangui. Open Journal of Obstetrics and Gynecology, 13, 950-959. https://doi.org/10.4236/ojog.2023.135081</p></sec></body><back><ref-list><title>References</title><ref id="scirp.125430-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Programme Commun des Nations Unies sur le Vih/Sida (ONUSIDA) (2020) L’homme au c&amp;#339;ur de la lutte contre les pandémies. Rapport de la journée mondiale de lutte contre le sida, 2020. 92 p.  
https://www.unaids.org/sites/default/files/media_asset/prevailing-against-pandemics_en.pdf</mixed-citation></ref><ref id="scirp.125430-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Joint United Nations Programme on HIV/AIDS (UNAIDS) (2021) Confronting Inequalities Lessons for Pandemic Responses from 40 years of AIDS. Global Aids Update. UNAIDS, Geneva, 386 p.  
https://www.unaids.org/sites/default/files/media_asset/2021-global-aids-update_en.pdf</mixed-citation></ref><ref id="scirp.125430-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ministere de la Sante et de la Population (2021) Guide de prévention de la transmission du VIH de la mère à l’enfant a l’intention des prestataires des sites PTPE, 125p.</mixed-citation></ref><ref id="scirp.125430-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ministere de la Sante et de la Population (2018) Directives nationales sur l’utilisation des antirétroviraux pour la prévention et le traitement de l’infection à VIH en République Centrafricaine. Quatrième édition. 71 p.</mixed-citation></ref><ref id="scirp.125430-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Joint United Nations Programme on HIV/AIDS (UNAIDS) (2020) Unaids Data 2020. Global Aids Update, 2020. 436 p.</mixed-citation></ref><ref id="scirp.125430-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Comite National de Lutte Contre le VIH/SIDA (2017) Plan de rattrapage d’urgence pour accélérer l’accès au traitement ARV en République Centrafricaine. CNLS RCA, 25 p.</mixed-citation></ref><ref id="scirp.125430-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Institut Centrafricain des Statistiques et des études économiques et Sociales(2010) Suivi de la situation des enfants, des femmes et des hommes. Enquête par grappes à indicateurs multiples-MICS couplée avec la sérologie VIH, RCA 2010. Rapport final, 354 p.</mixed-citation></ref><ref id="scirp.125430-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Diemer, S.-C.H., Longo, J.D., Tekpa, G., Gaunefet, C.E. and Ngbale, R.N. (2018) Facteurs associés à la divulgation du statut de séropositivité au VIH à Bangui. Santé publique, 30, 397-403. https://doi.org/10.3917/spub.183.0397</mixed-citation></ref><ref id="scirp.125430-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ministere de la Sante et de la Population (2021) Prise en Charge Intégrée de la Grossesse et de l’Accouchement dans le contexte de la Prévention de la Transmission Parents/Enfants du VIH: PCIGA (CPN/PTPE/PECP DU VIH). 139 p.</mixed-citation></ref><ref id="scirp.125430-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ministere de la Sante et de la Population (2020) Manuel de la consultation prénatale. 51 p.</mixed-citation></ref><ref id="scirp.125430-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2010) Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Recommendations for a Public Health Approach. WHO Press, Geneva.</mixed-citation></ref><ref id="scirp.125430-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2017) Global Guidance on Criteria and Processes for Validation: Elimination of Mother-to-Child Transmission of HIV and Syphilis. 2nd Edition, World Health Organization, Geneva, 52 p.</mixed-citation></ref><ref id="scirp.125430-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Mandelbrot, L., Berrébi, A., Matheron, S., Blanche, D., Tubiana, R., Rouzioux, C,. Auchergm, F., et al. (2014) Infection par le VIH et grossesse : nouvelles recommandations 2013 du groupe d’experts fran&amp;#231;ais. Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 43, 534-548. https://doi.org/10.1016/j.jgyn.2014.01.006</mixed-citation></ref><ref id="scirp.125430-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Darby, A. and Jones, S.H. (2021) World Health Organization Guidelines (Option A, B, and B+) for Antiretroviral Drugs to Treat Pregnant Women and Prevent HIV Infection in Infants. The Embryo Project Encyclopedia. The Embryo Project at Arizona State University, Tempe, 7 p.</mixed-citation></ref><ref id="scirp.125430-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Gabouga, .FL., Kobangué, L., Diemer, S.H., Guéréndo, P., Dibert Kamba, G.D., Sépou, A. and Gresenguet, G. (2019) Studies of the Risk Factors for HIV Transmission from Mothers Who Are Seropositive under B+ Option to Children in the MotherTo-Child Transmission Prevention Sites of the City of Bangui. Clinical Dermatology Open Access Journal, 4, 1-6. https://doi.org/10.23880/CDOAJ-16000177</mixed-citation></ref><ref id="scirp.125430-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Njom Nlend, A.E., Nguedou Marcelle, K., Koki Ndombo, P. and Brunelle Sandié, A. (2019) Efficacité à 12 mois de l’option B+ pour la prévention de la transmission du VIH de la mère à l’enfant à Yaoundé, Cameroun. Revue d’épidémiologie et de Santé Publique, 67, 163-167. https://doi.org/10.1016/j.respe.2019.03.119</mixed-citation></ref><ref id="scirp.125430-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Girma, M., Wendaferash, R., Shibru, H., Berhane, Y., Hoelscher, M. and Kroidl, A. (2017) Uptake and Performance of Prevention of Mother-to-Child Transmission and Early Infant Diagnosis in Pregnant HIV-Infected Women and Their Exposed Infants at Seven Health Centres in Addis Ababa, Ethiopia. Tropical Medicine &amp; International Health, 22, 765-775. https://doi.org/10.1111/tmi.12881</mixed-citation></ref><ref id="scirp.125430-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Diemer, S.C.H., Ngbale, R.N., Longo, J.D.D., Bami Dienhot, O. and Gaunefet, C.E. (2017) Les facteurs de risque de transmission du VIH de la mère à l’enfant à Bangui. Médecine et Santé Tropicales, 27, 195-199. https://doi.org/10.1684/mst.2017.0665</mixed-citation></ref><ref id="scirp.125430-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Ngbale, R.N., Komangoya, N.N., Diemer, H., Goddot Nangouma, M.J.C., Gaunefet, C.E., et al. (2013) Difficultés de la prévention de la transmission du VIH de la mère à l’enfant dans les maternités au sud du Sahara: Cas de la maternité de l’h&amp;#244;pital communautaire de Bangui. Médecine d’Afrique Noire, 60, 320-327.</mixed-citation></ref><ref id="scirp.125430-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Ahoua, L., Ayikoru, H., Gnauck, K., Odaru, G., Odar, E., Ondoa-Onama, C., et al. (2010) Evaluation of a 5-Year Programme to Prevent Mother-to-Child Transmission of HIV Infection in Northern Uganda. Journal of Tropical Pediatrics, 56, 43-52. https://doi.org/10.1093/tropej/fmp054</mixed-citation></ref><ref id="scirp.125430-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Hoffman, R., Black, V., Technau, K., Van Der Merwe, K.J., Currier, J., Coovadia, A., Chersich, M., et al. (2010) Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes, 54, 35-41. 
https://doi.org/10.1097/QAI.0b013e3181cf9979</mixed-citation></ref><ref id="scirp.125430-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Cissé, Z., Sangho, O., Telly, N., Traore, S., Sangho, F., Sangho, A., Touré, F., Sidibé, A., Traoré, M., Dembélé, H., Ke&amp;#239;ta, I., Camara, B. and Sacko, M. (2020) Facteurs associés à la transmission mère-enfant du VIH chez les enfants nés de mère séropositives à Bamako. Mali. Revue Malienne d’Infectiologie et de Microbiologie, 15, 30-37. https://doi.org/10.53597/remim.v15i2.1728</mixed-citation></ref><ref id="scirp.125430-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Beyene, G.A., Dadi, L.S. and Mogas, S.B. (2018) Determinants of HIV Infection Among Children Born to Mothers on Prevention of Mother to Child Transmission Program of HIV in Addis Ababa, Ethiopia: A Case Control Study. BMC Infectious Diseases, 18, 327-330. https://doi.org/10.1186/s12879-018-3217-3</mixed-citation></ref><ref id="scirp.125430-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Bucagu, M., Bizimana, J.D., Muganda, J. and Humblet, C.P. (2013) Socio-Economic, Clinical and Biological Risk Factors for Mother-to-Child Transmission of HIV-1 in Muhima Health Centre (Rwanda): A Prospective Cohort Study. Archives of Public Health, 71, Article No. 4. https://doi.org/10.1186/0778-7367-71-4</mixed-citation></ref><ref id="scirp.125430-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Mandelbrot, L. (2001) Syndrome d’immunodéficience acquise et grossesse. Encyclopédie Médico-Chirurgicale 5-039-D-40. Encyclopédie Médico-Chirurgicale, Paris, 23 p.</mixed-citation></ref><ref id="scirp.125430-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Medecins sans Frontieres (2020) Prévention de la Transmission du VIH de la mère a l’enfant—Protocole. 45 p.</mixed-citation></ref><ref id="scirp.125430-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Dorsaz, C. (2018) Pour quelles raisons, le taux de transmission verticale du Virus de l’Immunodéficience Humaine (VIH) durant l’accouchement et la période du post-partum reste élevé en Afrique de l’Est, malgré les programmes de prévention actuels. Mémoire pour l’obtention du Bachelor filière sage-femme, Haute Ecole de Sante, Genève, 71 p.</mixed-citation></ref><ref id="scirp.125430-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Landesman, S.H., Kalish, L.A., Burns, D.N., et al. (1996) Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to Child. New England Journal of Medicine, 334, 1617-1623.  
https://doi.org/10.1056/NEJM199606203342501</mixed-citation></ref><ref id="scirp.125430-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Chuachoowong, R., Shaffer, N., Siriwasin, W., et al. (2000) Short-Course Antenatal Zidovudine Reduces Both Cervicovaginal Human Immunodeficiency Virus Type 1 RNA Levels and Risk of Perinatal Transmission. The Journal of Infectious Diseases, 181, 99-106. https://doi.org/10.1086/315179</mixed-citation></ref><ref id="scirp.125430-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Magder, L.S., Mofenson, L., Paul, M.E., et al. (2005) Risk Factors for in Utero and Intrapartum Transmission of HIV. Journal of Acquired Immune Deficiency Syndromes, 38, 87-95. https://doi.org/10.1097/00126334-200501010-00016</mixed-citation></ref><ref id="scirp.125430-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Charurat, M., Datong, P., Matawal, B., Ajene, A., Blattner, W. and Abimiku, A. (2009) Timing and Determinants of Mother-to-Child Transmission of HIV in Nigeria. International Journal of Gynecology &amp; Obstetrics, 106, 8-13.  
https://doi.org/10.1016/j.ijgo.2009.02.017</mixed-citation></ref><ref id="scirp.125430-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Newell, M.L., Dunn, D., Peckham, C.S., et al. (1992) Risk Factors for Mother-to-Child Transmission of HIV-1. European Collaborative Study. Lancet, 339, 1007-1012.</mixed-citation></ref><ref id="scirp.125430-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Mok, J.Q., De Rossi, A., Ades, A.E., et al. (1987) Infants Born to Mothers Seropositive for Human Immunodeficiency Virus. Lancet, 329, 1164-1168.  
https://doi.org/10.1016/S0140-6736(87)92142-8</mixed-citation></ref><ref id="scirp.125430-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Oladokun, R.E., Brown, B.J. and Osinusi, K. (2010) Infant-Feeding Pattern of HIV-Positive Women in a Prevention of Mother-to-Child Transmission (PMTCT) Programme. AIDS Care, 22, 1108-1114.  
https://doi.org/10.1080/09540120903511008</mixed-citation></ref><ref id="scirp.125430-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Noubiap, J.J.N., Bongoe, A. and Demanou, S.A. (2013) Mother-to-Child Transmission of HIV: Findings from an Early Infant Diagnosis Program in Bertoua, Eastern Cameroon. Pan African Medical Journal, 15, Article 65.  
https://doi.org/10.11604/pamj.2013.15.65.2551</mixed-citation></ref><ref id="scirp.125430-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Iliff, P.J., Piwoz, E.G., Tavengwa, N.V., Zunguza, C.D., Marinda, E.T., Nathoo, K.J., et al. (2005) Early Exclusive Breastfeeding Reduces the Risk of Postnatal HIV-1 Transmission and Increases HIV-Free Survival. AIDS, 19, 699-708. 
https://doi.org/10.1097/01.aids.0000166093.16446.c9</mixed-citation></ref><ref id="scirp.125430-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Anoje, C., Aiyenigba, B., Suzuki, C., Badru, T., Akpoigbe, K., Odo, M., et al. (2012) Reducing Mother-to-Child Transmission of HIV: Findings from an Early Infant Diagnosis Program in South-South Region of Nigeria. BMC Public Health, 12, 184-187. https://doi.org/10.1186/1471-2458-12-184</mixed-citation></ref></ref-list></back></article>